🇺🇸 FDA
Patent

US 6933276

Methods of treating peripheral neuropathies using neurotrophin-3

expired A61KA61K38/00

Quick answer

US patent 6933276 (Methods of treating peripheral neuropathies using neurotrophin-3) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00